Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: Combined data from 4 clinical trials

Gregory A. Wiseman, Ellen Kornmehl, Bryan Leigh, William D. Erwin, Donald A. Podoloff, Stewart Spies, Richard B. Sparks, Michael G. Stabin, Thomas Witzig, Christine A. White

Research output: Contribution to journal › Article › peer-review

207 Scopus citations

Fingerprint

Dive into the research topics of 'Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: Combined data from 4 clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences